Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Shah AJ, Schwartz JD, Segovia JC. N Engl J Med 2022;386:2538-2539.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shah AJ, Schwartz JD, Segovia JC. Mitapivat versus Placebo for Pyruvate Kinase Deficiency. N Engl J Med 2022;386:2538-2539.
PMID: 35767453